How to Transport Secukinumab for International Travel
Secukinumab must be kept refrigerated at 2-8°C (36-46°F) during transport and should be carried in insulated cooling containers with ice packs, kept in carry-on luggage to maintain proper temperature control throughout the journey.
Storage and Transport Requirements
The FDA-approved secukinumab formulations (prefilled syringes, Sensoready pens, and UnoReady pens) are sterile solutions without preservatives that require specific handling 1. While the provided evidence doesn't explicitly detail storage temperature requirements, biologics like secukinumab universally require refrigeration to maintain stability and efficacy.
Practical Transport Strategy
For air travel:
- Use an insulated medical travel cooler with reusable ice packs or gel packs
- Place secukinumab in carry-on luggage (never checked baggage) to prevent temperature extremes and loss
- Bring a letter from your prescribing physician documenting medical necessity, dosing schedule, and that the medication requires refrigeration
- Carry the original prescription label and packaging
- Pack enough medication for the entire trip plus extra doses in case of travel delays
Temperature monitoring:
- Consider using a small thermometer in your cooling bag to verify temperature maintenance
- If ice packs thaw during long flights, request ice from flight attendants or access airport lounges with ice machines after security
- Upon arrival at your destination, immediately refrigerate the medication
Legal and Customs Considerations
Documentation is critical when traveling internationally with injectable biologics 2. Prepare:
- Physician's letter on official letterhead stating diagnosis, medication name (generic and brand), dosage, and medical necessity
- Original prescription with your name matching your passport
- Medication in original packaging with pharmacy labels intact
- Translation of medical documentation if traveling to non-English speaking countries
Check destination country regulations for importing medications, as requirements vary significantly 2. Some countries require advance notification or special permits for injectable medications.
Dosing Continuity During Travel
The standard secukinumab maintenance regimen is 300 mg every 4 weeks after the initial loading phase 3. Plan your travel dates around your dosing schedule to avoid missing doses, as interruptions can lead to disease flare. If you must travel during a scheduled dose:
- Bring sufficient supplies to self-administer on schedule
- Identify clean, private spaces for injection (hotel rooms are typically suitable)
- Follow proper injection technique as outlined in the Instructions for Use 1
- Dispose of used syringes/pens in a portable sharps container (bring one from home, as they may not be readily available abroad)
Sharps Disposal While Traveling
Bring an FDA-cleared sharps container or a heavy-duty plastic container with a secure, puncture-resistant lid 1. Research disposal regulations at your destination, as international requirements vary. Many hotels can assist with medical waste disposal if you explain the situation to management in advance.
Coordination with Healthcare Providers
Before departure, discuss your travel plans with your dermatologist or rheumatologist 4. This is particularly important for:
- Ensuring adequate medication supply
- Obtaining necessary documentation
- Planning for potential disease flares
- Coordinating with travel medicine specialists if visiting high-risk infectious disease areas (relevant given secukinumab's immunosuppressive effects)
Common Pitfalls to Avoid
- Never freeze secukinumab - frozen medication must be discarded
- Don't pack in checked luggage - temperature fluctuations in cargo holds can destroy the medication
- Don't wait until the last minute - obtain physician letters and check customs requirements weeks before departure
- Don't assume pharmacies abroad will have your medication - secukinumab availability varies internationally
- Don't skip doses - missing doses can trigger psoriasis flares that may take weeks to control 3
Duration Considerations
For extended international travel (>4 weeks), consider whether continuing biologic therapy abroad is feasible versus temporarily switching to alternative management strategies. Discuss this with your physician well in advance, as stopping secukinumab may require repeating loading doses upon return if more than 3-4 half-lives have passed 3.